CN1867548A - 3－氮杂双环[3.1.0]己烷衍生物的制备 - Google Patents

3－氮杂双环[3.1.0]己烷衍生物的制备 Download PDF

Info

Publication number
CN1867548A
CN1867548A CNA2004800305305A CN200480030530A CN1867548A CN 1867548 A CN1867548 A CN 1867548A CN A2004800305305 A CNA2004800305305 A CN A2004800305305A CN 200480030530 A CN200480030530 A CN 200480030530A CN 1867548 A CN1867548 A CN 1867548A
Authority
CN
China
Prior art keywords
phenyl
hydroxyl
alkyl
ethyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800305305A
Other languages
English (en)
Chinese (zh)
Inventor
乔萨姆·W·科
斯坦顿·F·麦克哈迪
约翰·A·拉根
德里克·L·蒂克纳
布赖恩·C·范德普拉斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of CN1867548A publication Critical patent/CN1867548A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CNA2004800305305A 2003-10-16 2004-10-06 3－氮杂双环[3.1.0]己烷衍生物的制备 Pending CN1867548A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51188903P 2003-10-16 2003-10-16
US60/511,889 2003-10-16

Publications (1)

Publication Number Publication Date
CN1867548A true CN1867548A (zh) 2006-11-22

Family

ID=34465290

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800305305A Pending CN1867548A (zh) 2003-10-16 2004-10-06 3－氮杂双环[3.1.0]己烷衍生物的制备

Country Status (17)

Country Link
US (1) US7129263B2 (https=)
EP (1) EP1675829A1 (https=)
JP (1) JP2007508367A (https=)
KR (1) KR20060096038A (https=)
CN (1) CN1867548A (https=)
AR (1) AR046592A1 (https=)
AU (1) AU2004281229A1 (https=)
BR (1) BRPI0415459A (https=)
CA (1) CA2540860A1 (https=)
CO (1) CO5680416A2 (https=)
IL (1) IL174596A0 (https=)
MX (1) MXPA06004278A (https=)
NO (1) NO20062152L (https=)
RU (1) RU2006112576A (https=)
TW (1) TW200524866A (https=)
WO (1) WO2005037790A1 (https=)
ZA (1) ZA200601964B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107428687A (zh) * 2015-05-20 2017-12-01 株式会社三和化学研究所 一种新型的3‑氮杂双环[3.1.0]己烷衍生物的盐的晶体以及其医药应用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003296324A1 (en) 2002-12-10 2004-06-30 Wyeth Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
KR20060095865A (ko) * 2003-10-14 2006-09-04 화이자 프로덕츠 인크. 글리신 수송 억제제로서의 비시클릭 [3.1.0] 유도체
WO2008075162A2 (en) * 2006-12-15 2008-06-26 Pfizer Limited Selective mu opioid receptor antagonists for the treatment of female sexual dysfunction
JP2013542929A (ja) 2010-09-28 2013-11-28 パナセア バイオテック リミテッド 新規ビシクロ環化合物
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
US9663463B2 (en) * 2013-11-20 2017-05-30 Sanwa Kagaku Kenkyusho Co., Ltd. 3-azabicyclo[3.1.0]hexane derivative and use thereof for medical purpose
US12356988B2 (en) 2018-03-05 2025-07-15 Corteva Agriscience Llc Process and intermediates for the preparation of certain mesoionic pesticides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI244481B (en) * 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
EP1440059B1 (en) * 2001-10-22 2008-04-16 Pfizer Products Inc. 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107428687A (zh) * 2015-05-20 2017-12-01 株式会社三和化学研究所 一种新型的3‑氮杂双环[3.1.0]己烷衍生物的盐的晶体以及其医药应用
CN107428687B (zh) * 2015-05-20 2021-06-11 宇部兴产株式会社 一种3-氮杂双环[3.1.0]己烷衍生物的盐的晶体以及其医药应用
CN113307760A (zh) * 2015-05-20 2021-08-27 宇部兴产株式会社 一种新型的3-氮杂双环[3.1.0]己烷衍生物的盐的晶体以及其医药应用

Also Published As

Publication number Publication date
RU2006112576A (ru) 2006-08-27
TW200524866A (en) 2005-08-01
AR046592A1 (es) 2005-12-14
BRPI0415459A (pt) 2006-12-19
US7129263B2 (en) 2006-10-31
WO2005037790A1 (en) 2005-04-28
CO5680416A2 (es) 2006-09-29
AU2004281229A1 (en) 2005-04-28
EP1675829A1 (en) 2006-07-05
CA2540860A1 (en) 2005-04-28
KR20060096038A (ko) 2006-09-05
US20050113437A1 (en) 2005-05-26
NO20062152L (no) 2006-05-12
ZA200601964B (en) 2007-04-25
IL174596A0 (en) 2006-08-20
MXPA06004278A (es) 2006-06-28
JP2007508367A (ja) 2007-04-05

Similar Documents

Publication Publication Date Title
CN1102596C (zh) 5H－噻唑并[3,2－a]嘧啶衍生物
CN1227237C (zh) 作为五羟色胺5－ht2受体拮抗剂的哌嗪基吡嗪化合物
CN1337963A (zh) 吡嗪并(氮杂)吲哚衍生物
CN1630636A (zh) 二氢吲哚衍生物及其作为5－ht2受体配体的用途
CN1639164A (zh) 含氮杂环化合物
CN1202105A (zh) 2－烷基吡咯烷化合物
CN1882534A (zh) N－[苯基(2－吡咯烷基)甲基]苯甲酰胺和n－[(2－氮杂环庚烷基)苯基甲基]苯甲酰胺衍生物,其制备和治疗用途
CN1376063A (zh) 环胺ccr3拮抗剂
CN1471394A (zh) 三肽酶抑制剂
CN1325399A (zh) 作为5－ht2c兴奋剂的吡咯并吲哚、吡啶并吲哚和氮杂草并吲哚
CN88102247A (zh) 新颖的吡唑并[3，4-d]嘧啶、其制备方法及其药物组合物
CN1100057C (zh) 色烯化合物、其制备方法及含有它们的药物组合物
CN1795176A (zh) 作为毒蕈碱受体拮抗剂的氮杂双环衍生物
CN1867548A (zh) 3－氮杂双环[3.1.0]己烷衍生物的制备
CN1175254A (zh) 用作纤维蛋白原拮抗剂的哌啶乙酸衍生物
CN1956962A (zh) 四氢异喹啉磺酰胺衍生物，其制备方法及其在治疗中的应用
CN1141773A (zh) 含6-氧代-氮杂䓬吲哚的药物的制备方法
CN1555355A (zh) 被取代的4-氨基环己醇衍生物
CN1164580C (zh) 用作5-羟色胺激活剂的二唑衍生物
CN1103774C (zh) 治疗淀粉样变性的亚氨基－氮杂－蒽环酮衍生物
CN1809574A (zh) 喹啉3－氨基苯并二氢吡喃衍生物
HK1093977A (en) Preparation of 3-azabicyclo [3.1.0] hexane derivatives
CN1158257C (zh) 新型氨基吡咯啉化合物、其制备方法以及含有它们的药物组合物
CN1705660A (zh) 新的2,3－二氢－4(1h)－吡啶酮衍生物、制备它们的方法及含有它们的药物组合物
CN1785982A (zh) 新的苯并噻嗪和苯并噻二嗪化合物、它们的制备方法及包含它们的药物组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1093977

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1093977

Country of ref document: HK